Developer docs
API playgroundTry for free, no card

Search company profiles

Vector Biolabs

Full company profile

uuid000ebuj

Namestring
Vector Biolabs
Legal namestring
Fortis Life Sciences, LLC
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Vector Biolabs is a custom viral vector provider specializing in AAV (Adeno-Associated Virus) and Adenovirus products for gene therapy research, disease modeling, target validation, small molecule screening, and neuroscience applications. Founded in 2004 and headquartered in Malvern, Pennsylvania, the company operates a U.S.-based manufacturing facility and maintains a catalog of more than 62,000 AAV items spanning over 62,000 genes (29,000 human, 27,000 mouse, 6,000 rat) and more than 85,000 adenovirus products, supported by a proprietary library of over 100,000 pre-synthesized cDNA clones. Its technology platform includes custom AAV design and packaging services, dual AAV split-gene vectors for payloads above 4.7kb, shRNA silencing products achieving 70% knockdown efficiency, and a Vector Designer online tool for serotype and promoter selection. All catalog products carry a guaranteed purity above 95%, with custom production delivered in 4-5 weeks and packaging in 2-3 weeks.

The company operates a hybrid revenue model combining direct-to-consumer e-commerce sales of catalog products priced between $475 and $995 per unit with quote-based custom production services for pharmaceutical, biotechnology, academic, and government research buyers. Its customers include the National Institutes of Health, the University of Pennsylvania, the Medical University of South Carolina, and a network of featured international distributors. Vector Biolabs is a subsidiary brand of Fortis Life Sciences, LLC, a privately-held life sciences platform headquartered in Boston, Massachusetts, whose portfolio also includes Bethyl Laboratories, Vector Biosystems, Empirical Bioscience, Arista Biologicals, nanoComposix, and IPOC Holdings. The company employs 11-50 staff, holds no disclosed patents, trademarks, or external awards, and does not publicly report revenue or funding.

Short descriptiontext

Vector Biolabs, founded in 2004 and based in Malvern, Pennsylvania, is a subsidiary of Fortis Life Sciences that designs and manufactures custom AAV and Adenovirus viral vectors for gene therapy research, serving academic institutions, government agencies, pharmaceutical and biotechnology companies worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMalvern, United States
HQ citystring
Malvern
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
viral vector manufacturing, AAV gene delivery, adenovirus vectors, custom plasmid packaging, shRNA gene silencing
Industry3 codes
PRIMARYHLAAAKAD
Viral Vector Manufacturing Services (AAV, lentiviral, adenoviral)
SECONDARYHLAGAGAB
Gene Therapy CDMO (Viral Vector Manufacturing)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAACAJ
Gene Therapy Vector Manufacturing & CDMO Services
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Biological Products, (No Disgnostic Substances)2836
Product category
Viral Vector Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Catalog Product Sales
TypeOne Time License
Description

One-time sales of pre-made AAV and Adenovirus catalog products including control vectors, reporter genes, and shRNA constructs. Products are sold as ready-to-use viral particles with immediate availability for catalog items.

vectorbiolabs.com
2Custom Production Services
TypeOne Time License
Description

Custom AAV and Adenovirus vector design and production services tailored to specific research needs. Services include custom cloning, plasmid packaging, amplification, and purification. Pricing is quote-based.

vectorbiolabs.com
3shRNA Screening/Validation Services
TypeProfessional Services
Description

Specialized services for gene silencing studies including custom shRNA design, screening, and validation for specific target genes.

vectorbiolabs.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details5 tiers
1AAV Catalog Products - $495 per unit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

AAV products including LacZ, GFP, Cre recombinase variants priced at $495.00 per unit. Available in multiple serotypes (AAV1, AAV2, AAV5, AAV6, AAV9).

vectorbiolabs.com
2Adenovirus Catalog Products - $475 per unit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Adenovirus products including luciferase reporters, overexpression constructs priced at $475.00 per unit.

vectorbiolabs.com
3shRNA Control Products - $475 per unit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

shRNA control products with reporter genes (GFP, CFP, YFP, RFP, mCherry) priced at $475.00 per unit.

vectorbiolabs.com
4Gene-specific shRNA Products - $995 per unit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Gene-specific shRNA products for silencing studies priced at $995.00 per unit.

vectorbiolabs.com
5Custom Production Services - Quote-based pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Custom AAV and Adenovirus production services priced based on project requirements. Requires quote request through website. Delivery times 4-5 weeks for custom production.

vectorbiolabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Vector Biolabs designs, manufactures, and supplies custom and catalog viral vectors — primarily AAV (Adeno-Associated Virus) and Adenovirus — for gene therapy, disease modeling, target validation, small molecule screening, and neuroscience research. The company serves academic, government, and pharmaceutical/biotech customers with ready-to-use catalog products and custom production services backed by more than 20 years of plasmid packaging expertise.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • >95% purity guaranteed on all viral vector products
+1 more record
Product overview1 text field

Vector Biolabs is a custom viral vector provider specializing in AAV (Adeno-Associated Virus) and Adenovirus products for biomedical research and therapeutic development. The company offers a dual approach combining custom production services (AAV Custom Production, AAV Packaging, Adenovirus Construction, Adenovirus Amplification, and shRNA Screening/Validation) with an extensive catalog of ready-to-use products. The product portfolio includes over 62k AAV catalog items covering human, mouse, and rat genes, over 85k adenovirus products, and comprehensive shRNA products for gene silencing. They also provide a Vector Designer tool for custom vector design. Key applications span gene therapy research, disease modeling, target validation, small molecule screening, and neuroscience.

Product and service8 records
1AAV Custom Production
CategoryViral Vector Custom Services
Description

Custom AAV (Adeno-Associated Virus) vector design and construction service that delivers tailored designs for specific research requirements, with 4-5 week turnaround from design to delivery. Targeted at academic, government, and pharmaceutical researchers needing bespoke AAV constructs.

2AAV Packaging (Plasmid Packaging)
CategoryViral Vector Custom Services
Description

Plasmid packaging service that produces high-quality, reliable AAV vectors from submitted plasmids in 2-3 weeks, with flexible support for both internally produced and externally produced plasmids. Targeted at researchers with validated plasmid constructs needing AAV production.

3AAV Product Catalog
CategoryViral Vector Catalog Products
Description

Ready-to-use catalog of AAV vectors covering multiple serotypes and variants including overexpression, shRNA silencing, Cre/FLP recombinases, CRISPR/Cas9, and control/reporter products, priced at $495 per unit. Targeted at researchers needing immediate availability of standard AAV constructs.

4Adenovirus Construction
CategoryViral Vector Custom Services
Description

Custom adenovirus construction service using the Ad-HQ system to produce high-yield custom adenovirus vectors with fast turnaround. Targeted at researchers needing tailored adenovirus constructs for gene delivery studies.

5Adenovirus Amplification
CategoryViral Vector Custom Services
Description

Adenovirus amplification service that scales up production for in-vivo studies or generates high-titer purified adenovirus preparations. Targeted at researchers needing larger volumes or higher titers for animal studies.

6Adenovirus Product Catalog
CategoryViral Vector Catalog Products
Description

Catalog of ready-to-use adenovirus vectors including overexpression, calcium indicators (GECI), CRISPR/Cas9, fiber-modified Ad5, iPS stem cell factors, luciferase reporters, and recombinase products, priced at $475 per unit. Targeted at researchers needing standard adenovirus constructs with immediate availability.

7shRNA Screening/Validation Service
CategoryViral Vector Custom Services
Description

Specialized service for gene silencing studies using shRNA technology, including custom shRNA design, screening, and validation for specific target genes, delivered via AAV or Adenovirus platforms. Targeted at researchers conducting functional genomics and target validation studies.

8shRNA Product Catalog
CategoryViral Vector Catalog Products
Description

Catalog of shRNA products for gene silencing available in both AAV and Adenovirus formats with various reporter options including GFP, CFP, YFP, RFP, and mCherry, achieving 70% knockdown efficiency. Control shRNA priced at $475 per unit; gene-specific shRNA priced at $995 per unit.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Vector Biolabs is a subsidiary and brand of Fortis Life Sciences, a privately-held life sciences company headquartered in Boston, Massachusetts. Fortis Life Sciences operates multiple brands including Bethyl Laboratories, Vector Biosystems, Empirical Bioscience, Arista Biologicals, nanoComposix, and IPOC Holdings. Fortis provides the corporate infrastructure, governance, and resources for Vector Biolabs operations.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Aldevron, now part of Danaher, manufactures plasmids, mRNA, and viral vectors including AAV. It is a broader incumbent offering high-quality research- and GMP-grade viral vector services comparable to Vector Biolabs' offerings.

TypeBroad incumbent
Description

Through its Brammer Bio viral vector CDMO business, Thermo Fisher is a major incumbent in AAV and other viral vector manufacturing. It represents the largest-scale competitor to Vector Biolabs in custom viral vector services.

TypeBroad incumbent
Description

Charles River acquired Vigene Biosciences to provide viral vector (AAV, lentivirus) manufacturing services. It competes with Vector Biolabs on custom viral vector production, especially for higher-grade preclinical and clinical work.

TypeBroad incumbent
Description

Lonza is a global CDMO with significant viral vector and cell & gene therapy manufacturing capacity. It is a broader incumbent that overlaps with Vector Biolabs in custom AAV/adenoviral vector services for biotech customers.

TypeDirect peer
Description

PackGene Biotech is a CDMO specializing in AAV and lentiviral vector manufacturing with catalog and custom services. It directly competes with Vector Biolabs for AAV gene delivery projects from academic and biotech customers.

6Vigene Biosciences
TypeDirect peer
Description

Vigene Biosciences specializes in AAV and lentiviral vector production services for gene therapy research and preclinical applications. Its service portfolio and target customer base closely align with Vector Biolabs' custom production offering.

TypeEmerging player
Description

Cell Biolabs provides viral tools and reagents including adenoviral and lentiviral products for research. It is a comparable niche tools provider serving similar academic and biotech research customers.

TypeEmerging player
Description

GenScript offers gene synthesis, plasmid, and viral vector services including AAV and lentivirus. It overlaps with Vector Biolabs as a one-stop shop for researchers needing genes plus viral delivery.

TypeDirect peer
Description

Addgene is a major nonprofit plasmid and viral vector repository serving the research community. It competes with Vector Biolabs on catalog breadth for ready-to-use AAV and lentiviral reagents.

TypeDirect peer
Description

VectorBuilder is a direct competitor offering custom AAV, lentiviral, and other viral vector design and manufacturing services with an extensive online catalog — closely mirroring Vector Biolabs' catalog-plus-custom model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vector Biolabs

Viral Vector Manufacturingvectorbiolabs.com

Vector Biolabs, founded in 2004 and based in Malvern, Pennsylvania, is a subsidiary of Fortis Life Sciences that designs and manufactures custom AAV and Adenovirus viral vectors for gene therapy research, serving academic institutions, government agencies, pharmaceutical and biotechnology companies worldwide.

What Vector Biolabs does

Vector Biolabs is a custom viral vector provider specializing in AAV (Adeno-Associated Virus) and Adenovirus products for gene therapy research, disease modeling, target validation, small molecule screening, and neuroscience applications. Founded in 2004 and headquartered in Malvern, Pennsylvania, the company operates a U.S.-based manufacturing facility and maintains a catalog of more than 62,000 AAV items spanning over 62,000 genes (29,000 human, 27,000 mouse, 6,000 rat) and more than 85,000 adenovirus products, supported by a proprietary library of over 100,000 pre-synthesized cDNA clones. Its technology platform includes custom AAV design and packaging services, dual AAV split-gene vectors for payloads above 4.7kb, shRNA silencing products achieving 70% knockdown efficiency, and a Vector Designer online tool for serotype and promoter selection. All catalog products carry a guaranteed purity above 95%, with custom production delivered in 4-5 weeks and packaging in 2-3 weeks.

The company operates a hybrid revenue model combining direct-to-consumer e-commerce sales of catalog products priced between $475 and $995 per unit with quote-based custom production services for pharmaceutical, biotechnology, academic, and government research buyers. Its customers include the National Institutes of Health, the University of Pennsylvania, the Medical University of South Carolina, and a network of featured international distributors. Vector Biolabs is a subsidiary brand of Fortis Life Sciences, LLC, a privately-held life sciences platform headquartered in Boston, Massachusetts, whose portfolio also includes Bethyl Laboratories, Vector Biosystems, Empirical Bioscience, Arista Biologicals, nanoComposix, and IPOC Holdings. The company employs 11-50 staff, holds no disclosed patents, trademarks, or external awards, and does not publicly report revenue or funding.

Vector Biolabs firmographics

Firmographics
Name
Vector Biolabs
Legal name
Fortis Life Sciences, LLC
Website
https://vectorbiolabs.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Vector Biolabs, founded in 2004 and based in Malvern, Pennsylvania, is a subsidiary of Fortis Life Sciences that designs and manufactures custom AAV and Adenovirus viral vectors for gene therapy research, serving academic institutions, government agencies, pharmaceutical and biotechnology companies worldwide.
Ownership category
akta.pro rank

Vector Biolabs industry classification

Industry
Product category
Viral Vector Manufacturing
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAKAD
Viral Vector Manufacturing Services (AAV, lentiviral, adenoviral)
SECONDARYHLAGAGAB
Gene Therapy CDMO (Viral Vector Manufacturing)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAACAJ
Gene Therapy Vector Manufacturing & CDMO Services
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)

Keywords

  • Viral vector manufacturing
  • AAV gene delivery
  • Adenovirus vectors
  • Custom plasmid packaging
  • ShRNA gene silencing

Where Vector Biolabs is headquartered

Location

Headquarters

HQ city
Malvern
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Vector Biolabs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Catalog Product Sales: One-time sales of pre-made AAV and Adenovirus catalog products including control vectors, reporter genes, and shRNA constructs. Products are sold as ready-to-use viral particles with immediate availability for catalog items.
  2. Custom Production Services: Custom AAV and Adenovirus vector design and production services tailored to specific research needs. Services include custom cloning, plasmid packaging, amplification, and purification. Pricing is quote-based.
  3. shRNA Screening/Validation Services: Specialized services for gene silencing studies including custom shRNA design, screening, and validation for specific target genes.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goAAV Catalog Products - $495 per unit
Unit PricingPay-as-you-goAdenovirus Catalog Products - $475 per unit
Unit PricingPay-as-you-goshRNA Control Products - $475 per unit
Unit PricingPay-as-you-goGene-specific shRNA Products - $995 per unit
OtherPay-as-you-goCustom Production Services - Quote-based pricing

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Vector Biolabs product offering

Product offering

Core offering

Vector Biolabs designs, manufactures, and supplies custom and catalog viral vectors — primarily AAV (Adeno-Associated Virus) and Adenovirus — for gene therapy, disease modeling, target validation, small molecule screening, and neuroscience research. The company serves academic, government, and pharmaceutical/biotech customers with ready-to-use catalog products and custom production services backed by more than 20 years of plasmid packaging expertise.

Product overview

Vector Biolabs is a custom viral vector provider specializing in AAV (Adeno-Associated Virus) and Adenovirus products for biomedical research and therapeutic development. The company offers a dual approach combining custom production services (AAV Custom Production, AAV Packaging, Adenovirus Construction, Adenovirus Amplification, and shRNA Screening/Validation) with an extensive catalog of ready-to-use products. The product portfolio includes over 62k AAV catalog items covering human, mouse, and rat genes, over 85k adenovirus products, and comprehensive shRNA products for gene silencing. They also provide a Vector Designer tool for custom vector design. Key applications span gene therapy research, disease modeling, target validation, small molecule screening, and neuroscience.

Differentiator

Problem solved

Functional benefit

Products and services

  • AAV Custom Production Custom AAV (Adeno-Associated Virus) vector design and construction service that delivers tailored designs for specific research requirements, with 4-5 week turnaround from design to delivery. Targeted at academic, government, and pharmaceutical researchers needing bespoke AAV constructs.
  • AAV Packaging (Plasmid Packaging) Plasmid packaging service that produces high-quality, reliable AAV vectors from submitted plasmids in 2-3 weeks, with flexible support for both internally produced and externally produced plasmids. Targeted at researchers with validated plasmid constructs needing AAV production.
  • AAV Product Catalog Ready-to-use catalog of AAV vectors covering multiple serotypes and variants including overexpression, shRNA silencing, Cre/FLP recombinases, CRISPR/Cas9, and control/reporter products, priced at $495 per unit. Targeted at researchers needing immediate availability of standard AAV constructs.
  • Adenovirus Construction Custom adenovirus construction service using the Ad-HQ system to produce high-yield custom adenovirus vectors with fast turnaround. Targeted at researchers needing tailored adenovirus constructs for gene delivery studies.
  • Adenovirus Amplification Adenovirus amplification service that scales up production for in-vivo studies or generates high-titer purified adenovirus preparations. Targeted at researchers needing larger volumes or higher titers for animal studies.
  • Adenovirus Product Catalog Catalog of ready-to-use adenovirus vectors including overexpression, calcium indicators (GECI), CRISPR/Cas9, fiber-modified Ad5, iPS stem cell factors, luciferase reporters, and recombinase products, priced at $475 per unit. Targeted at researchers needing standard adenovirus constructs with immediate availability.
  • shRNA Screening/Validation Service Specialized service for gene silencing studies using shRNA technology, including custom shRNA design, screening, and validation for specific target genes, delivered via AAV or Adenovirus platforms. Targeted at researchers conducting functional genomics and target validation studies.
  • shRNA Product Catalog Catalog of shRNA products for gene silencing available in both AAV and Adenovirus formats with various reporter options including GFP, CFP, YFP, RFP, and mCherry, achieving 70% knockdown efficiency. Control shRNA priced at $475 per unit; gene-specific shRNA priced at $995 per unit.

Quantifiable outcome

  • >95% purity guaranteed on all viral vector products
  • +1 more outcomes

Companies that use Vector Biolabs

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Vector Biolabs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Vector Biolabs partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Fortis Life Sciences, LLCcoreOthersVector Biolabs is a subsidiary and brand of Fortis Life Sciences, a privately-held life sciences company headquartered in Boston, Massachusetts. Fortis Life Sciences operates multiple brands including Bethyl Laboratories, Vector Biosystems, Empirical Bioscience, Arista Biologicals, nanoComposix, and IPOC Holdings. Fortis provides the corporate infrastructure, governance, and resources for Vector Biolabs operations.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Vector Biolabs competitors and assessment

Company assessment

Broad incumbents

  • Aldevron (Danaher): Aldevron, now part of Danaher, manufactures plasmids, mRNA, and viral vectors including AAV. It is a broader incumbent offering high-quality research- and GMP-grade viral vector services comparable to Vector Biolabs' offerings.
  • Thermo Fisher Scientific (Brammer Bio): Through its Brammer Bio viral vector CDMO business, Thermo Fisher is a major incumbent in AAV and other viral vector manufacturing. It represents the largest-scale competitor to Vector Biolabs in custom viral vector services.
  • Charles River Laboratories (Vigene Biosciences): Charles River acquired Vigene Biosciences to provide viral vector (AAV, lentivirus) manufacturing services. It competes with Vector Biolabs on custom viral vector production, especially for higher-grade preclinical and clinical work.
  • Lonza: Lonza is a global CDMO with significant viral vector and cell & gene therapy manufacturing capacity. It is a broader incumbent that overlaps with Vector Biolabs in custom AAV/adenoviral vector services for biotech customers.

Direct peers

  • PackGene Biotech: PackGene Biotech is a CDMO specializing in AAV and lentiviral vector manufacturing with catalog and custom services. It directly competes with Vector Biolabs for AAV gene delivery projects from academic and biotech customers.
  • Vigene Biosciences: Vigene Biosciences specializes in AAV and lentiviral vector production services for gene therapy research and preclinical applications. Its service portfolio and target customer base closely align with Vector Biolabs' custom production offering.
  • Addgene: Addgene is a major nonprofit plasmid and viral vector repository serving the research community. It competes with Vector Biolabs on catalog breadth for ready-to-use AAV and lentiviral reagents.
  • VectorBuilder: VectorBuilder is a direct competitor offering custom AAV, lentiviral, and other viral vector design and manufacturing services with an extensive online catalog — closely mirroring Vector Biolabs' catalog-plus-custom model.

Emerging players

  • Cell Biolabs: Cell Biolabs provides viral tools and reagents including adenoviral and lentiviral products for research. It is a comparable niche tools provider serving similar academic and biotech research customers.
  • GenScript: GenScript offers gene synthesis, plasmid, and viral vector services including AAV and lentivirus. It overlaps with Vector Biolabs as a one-stop shop for researchers needing genes plus viral delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Vector Biolabs social profiles

Digital presence

Vector Biolabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vector Biolabs leadership team

Management profile

Number of profiles

Vector Biolabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vector Biolabs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vector Biolabs

What does Vector Biolabs do?

Vector Biolabs designs, manufactures, and supplies custom and catalog viral vectors — primarily AAV (Adeno-Associated Virus) and Adenovirus — for gene therapy, disease modeling, target validation, small molecule screening, and neuroscience research. The company serves academic, government, and pharmaceutical/biotech customers with ready-to-use catalog products and custom production services backed by more than 20 years of plasmid packaging expertise.

Is Vector Biolabs a public or private company?

Vector Biolabs is a private company. It is classified as corporate owned and is currently operating.

When was Vector Biolabs founded?

Vector Biolabs was founded in 2004. It employs 11 to 50 people.

Where is Vector Biolabs based?

Vector Biolabs is headquartered in Malvern, United States, in the North America region.

How does Vector Biolabs make money?

Three revenue lines are on record. Catalog Product Sales are the primary driver. The others are custom Production Services and shRNA Screening/Validation Services.

Who are Vector Biolabs's main competitors?

Broad incumbents on record are Aldevron (Danaher), Thermo Fisher Scientific (Brammer Bio), Charles River Laboratories (Vigene Biosciences) and Lonza. Direct peers are PackGene Biotech, Vigene Biosciences, Addgene and VectorBuilder. Emerging players are Cell Biolabs and GenScript.

Does Vector Biolabs have an API?

No public API is recorded for Vector Biolabs.

What industry is Vector Biolabs in?

Vector Biolabs's product category is Viral Vector Manufacturing. Its primary akta.pro industry code is HLAAAKAD, Viral Vector Manufacturing Services (AAV, lentiviral, adenoviral), with a secondary code of HLAGAGAB, Gene Therapy CDMO (Viral Vector Manufacturing). Its NAICS code is 325414 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales